📄 Cross-examination of Dr. Robin Cotton (part 2) — Friday, May 12, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\12\CROSS-EXAMINATION-OF-DR-ROBIN-.DOC
TRIAL
▲ Day 73 of 167

Cross-examination of Dr. Robin Cotton (part 2)

Witness: Dr. Robin Cotton
Examiner: Peter Neufeld
Called by: Prosecution • Date: Friday, May 12, 1995 • Utterances: 531
Defense attorney Peter Neufeld cross-examines Cellmark Diagnostics lab director Dr. Robin Cotton, methodically attacking the DNA evidence through three angles: (1) a visual demonstration showing how degradation and cross-contamination could produce false results, (2) comparing Cellmark's rigorous contamination protocols against implied LAPD failures, and (3) exposing weaknesses in the mixed DNA stain from the Bronco steering wheel. The examination builds a cumulative argument that evidence mishandling could have introduced OJ Simpson's DNA onto crime scene swatches rather than it being deposited there by Simpson.
1 MR. NEUFELD:

Dr. Cotton--

2 MR. NEUFELD:

Good morning still.

THE JURY: Good morning.

3 MR. NEUFELD:

Dr. Cotton, I'd just shown you those two photographs comparing the swatches in item 47 and item 12. Do you recall that?

4 DR. COTTON:

Yes.

5 MR. NEUFELD:

Okay. Now, what I would like to do is just show you a computer graphic that was created, and I wanted to ask you some questions about it, Dr. Cotton.

6 MR. NEUFELD:

And this, your Honor--this will be Defendant's 1149-a though l.

7 THE COURT:

What happened to 1148?

8 MR. NEUFELD:

1148 was a printout of the side-by-side.

9 THE COURT:

All right.

10 (Deft's 1149-a through l for id = computer graphic)
11 (Brief pause.)
12 MR. NEUFELD:

I don't know if it's easier for you to look up or down, Dr. Cotton.

13 DR. COTTON:

Uh, I don't know. I'd rather come down here and look if that's allowable.

14 MR. NEUFELD:

Whichever is your pleasure, ma'am.

15 THE COURT:

All right. Just long as the court reporter and the jury can hear.

16 MR. NEUFELD:

All right. Dr. Cotton, what I would like you to do for the purposes of this demonstration visualization is assume that that red rectangle is a swatch, a bloodstain swatch. Obviously a bloodstain swatch is much, much smaller than that, right, Dr. Cotton?

17 DR. COTTON:

Most of them are.

18 MR. NEUFELD:

As collected in a crime scene.

19 DR. COTTON:

Yes.

20 MR. NEUFELD:

And certainly the ones in this case are a heck of a lot smaller, aren't they?

21 DR. COTTON:

Yes.

22 MR. NEUFELD:

Okey-doke. And in the illustration, Dr. Cotton, this is a blood swatch representing the bloodstain on it coming from person 1. And on that blood swatch, I have placed a number 1 four times to suggest a certain quantity, whatever it is, of DNA present in that swatch.

23 DR. COTTON:

Okay.

24 MR. NEUFELD:

Okay? And now--

25 MR. NEUFELD:

Could you please show b?

26 MR. NEUFELD:

Now, would you agree, Dr. Cotton, that sealing that swatch in a plastic bag, if it is moist, if the swatch itself is still wet, can cause degradation of the DNA?

27 DR. COTTON:

Over time, degradation will occur.

28 MR. NEUFELD:

And that--okay. And putting it in a plastic bag as opposed to a paper bag, for instance, enhances that degradation; isn't that correct?

29 DR. COTTON:

I don't think that, again, for the short term, it's going to make any difference. For a longer term, it would.

30 MR. NEUFELD:

And when you say it would, it would make a difference whether it's packaged in a plastic bag as opposed to say a brown paper bag?

31 DR. COTTON:

Yes.

32 MR. NEUFELD:

Okay. Would you please show the next one.

33 MR. NEUFELD:

And if you added to that plastic bag the factor of heat, the element of heat, would that even further enhance the degradation?

34 DR. COTTON:

It probably would, yes.

35 MR. NEUFELD:

Okay. And could you now add the next one.

36 MR. NEUFELD:

And again, just to reiterate what I think you're already said, that as long as the blood swatch remains moist, that degradation will continue; is that correct?

37 DR. COTTON:

Yes.

38 MR. NEUFELD:

Okay. Can you do the next one, please.

39 MR. CLARKE:

I'm going to object at this point as to foundation and relevance. Assuming facts not in evidence.

40 THE COURT:

Overruled.

41 MR. NEUFELD:

And I think finally here, the last element that you talked about before was the factor called time. And the longer the blood swatch is wet and remains in that plastic bag and subjected to heat and moisture, the more it will degrade.

42 DR. COTTON:

Yes. That was--that's probably going to be the case.

43 MR. NEUFELD:

Okay. Now--

44 MR. CLARKE:

Excuse me, your Honor. I'm going to enter another objection under 352 as to misleading. As far as the graphics is what I'm referring to.

45 THE COURT:

All right. Were they shown to you previously?

46 MR. CLARKE:

Yes.

47 THE COURT:

All right. Overruled.

48 MR. NEUFELD:

And you said, Dr. Cotton, I believe yesterday that it is possible that the DNA can become so degraded in the swatch that although the swatch still appears red, it will have no identifiable DNA in it or human DNA in it; is that correct? That's possible?

49 DR. COTTON:

Over a very long period of--in order for it to not have--you won't get to the point where you don't have small bits of DNA, but you can get to the point where the degradation is so substantial that you can't easily measure it by the methods that are generally used in a forensic laboratory.

50 MR. NEUFELD:

So what we're really talking about is the DNA's detectability. That's what lost through time, moisture, heat?

51 DR. COTTON:

Yes.

52 MR. NEUFELD:

Okay. Could you please go to the next one.

53 MR. NEUFELD:

Now, take that blood swatch which has now been completely degraded and assume for a moment that it is cross-contaminated with another--

54 (Brief pause.)
55 MR. NEUFELD:

One moment.

56 (Brief pause.)
57 MR. NEUFELD:

Now, assume that the degradation was so complete, as you just described it, that the DNA was no longer detectable.

58 MR. NEUFELD:

Would you please show the next slide?

59 MR. NEUFELD:

If you ran a DNA test on it under those circumstances, you would get, I believe you said, no result; is that correct?

60 MR. CLARKE:

Objection. Assumes facts not in evidence.

61 THE COURT:

Overruled.

62 DR. COTTON:

Depending on the level of degradation, it can be so degraded that you don't get an RFLP result, and if the level of degradation can become so much, that you won't even get a PCR result.

63 MR. NEUFELD:

Now--

64 MR. NEUFELD:

One moment.

65 (Brief pause.)
66 MR. NEUFELD:

Would you please put up 14-n, please?

67 MR. NEUFELD:

Now, if you take that blood swatch originally that came from person 1 and you brought it into actual contact with a wet blood swatch from person 2, all with fresh blood from person 2, could that cause cross-contamination as to the blood swatch that originally had the sample from person 1?

68 MR. CLARKE:

Objection. Improper hypothetical, assumes facts not in evidence.

69 THE COURT:

Overruled.

70 DR. COTTON:

If the hypothetical is as you're suggesting where you have a blood swatch and it no longer has typeable DNA from person 1 and somehow it comes into contact with a second swatch that's wet in such a way that they are so closely connected as to transfer a sufficient amount of DNA to be typed or a liquid blood sample--and same thing. You have to transfer a sufficient amount of DNA to be typed--then of course your hypothetical would be correct.

71 MR. NEUFELD:

And by the way, Dr. Cotton, I think you said, for instance, in sample 52, there was approximately 25 nanograms of DNA present in that--in that--for that DNA test; is that right?

72 DR. COTTON:

What I--what I said about sample 52 was--are you asking me about the RFLP result or the PCR result?

73 MR. NEUFELD:

I asked you about the RFLP result, to estimate approximately how much DNA was loaded in the lane. Wasn't your initial testimony that there was approximately 25 nanograms of DNA in that lane?

74 DR. COTTON:

That is correct, and that is what I said yesterday. What I said yesterday, however, wasn't completely precise, and I can clarify it if you wish me to.

75 MR. NEUFELD:

Go ahead and clarify that, please, Dr. Cotton.

76 DR. COTTON:

When I made an estimation that there was 25 to 50 nanograms of DNA for the RFLP result, what--what I was doing in my head was saying, if I compared--and these things have been done in the lab. So I have some mental image of this. If I took a known sample of specific quantities of DNA that was in good condition and I loaded different amounts on a gel, the intensity of the banding pattern that I'm seeing from item 52 is about the same as I might expect to see for--for 25 to 50 nanograms. Now, if you look at the DNA in item 52 on the small gel as it was originally--on the mini gel to see how degraded it was, you see that there's DNA all the way from the top of the gel all the way on down, meaning it's quite degraded. Only the only the high mole--only the big pieces of DNA--

77 THE COURT:

Dr. Cotton, can you keep your voice up, please?

78 DR. COTTON:

Yes. Only the big pieces of DNA of that--out of that sample can participate in the RFLP pattern. So whereas it's clear that there's mass wise, that is total quantity from the slot blot, there is more than 25 or 50 nanograms. What I was telling you was that the pattern--

79 MS. CLARK:

Could we ask Miss Cotton to return to the microphone?

80 MR. NEUFELD:

Actually, she can return to the witness stand for this.

81 THE COURT:

All right.

82 MR. NEUFELD:

Would you please, Dr. Cotton?

83 (The witness complies.)
84 DR. COTTON:

What I was telling you is that the pattern was the equivalent of 25 or 50 nanograms of DNA that's in good condition. So more DNA existed in that whole sample, but the amount that could be participating in the RFLP had to be that portion that was in good enough condition, and that would have been some much smaller portion than the whole sample.

85 MR. NEUFELD:

And, Dr. Cotton, when you described that--was it a yield gel where the DNA is spread out along the whole length of it?

86 DR. COTTON:

Yes.

87 MR. NEUFELD:

On the yield gel test--and correct me if I'm mistaken--you will not be able to distinguish bacterial DNA that is present from human DNA; is that correct.

88 DR. COTTON:

That's also correct.

89 MR. NEUFELD:

Okay. Now, getting back then to the illustration in this particular slide, if sufficient quantity of either fresh blood from a reference sample or--

90 THE COURT:

Excuse me. Counsel, this is the fourth time we're asking this question.

91 MR. NEUFELD:

Okay. I'll move on to the next slide.

92 THE COURT:

All right.

93 MR. NEUFELD:

Could you move on to I?

94 MR. NEUFELD:

Now, in this example that I put up there, slide I, you have a situation where the initial swatch has now been cross-contaminated with biological material from person number 2. Do you see that?

95 DR. COTTON:

Yes. You have three 2's up there.

96 MR. NEUFELD:

Right. And that's--the three 2's is simply to indicate that much more of person 2's DNA is on that swatch than person 1's.

97 DR. COTTON:

Okay.

98 MR. NEUFELD:

Due to the combined factors of degradation followed by cross-contamination, okay?

99 DR. COTTON:

Okay.

100 MR. NEUFELD:

Next slide is j? J, please.

101 MR. NEUFELD:

Now, if under this hypothetical, if you were then to do a DNA test, for instance, an RFLP test on a swatch that went through this process, wouldn't the RFLP test give you a profile of a person 2 rather than person 1?

102 DR. COTTON:

Yes.

103 MR. NEUFELD:

And if the degradation was sufficiently complete as to person 1, wouldn't it also give you a PCR result for person 2 as opposed to person 1?

104 DR. COTTON:

If the degradation was extremely extensive, then yes.

105 MR. NEUFELD:

Thank you. Now, one of the things I believe you said on direct examination, Dr. Cotton, was that the presence of soil and leaves mixing with the bloodstain can cause degradation; is that correct?

106 DR. COTTON:

Yes.

107 MR. NEUFELD:

First of all--

108 MR. NEUFELD:

Let's go to the board.

109 (Brief pause.)
110 THE COURT:

And this is People's exhibit?

111 MR. NEUFELD:

165, your Honor.

112 THE COURT:

All right. Thank you, counsel.

113 MR. NEUFELD:

And, Dr. Cotton, would you come down and take a quick look at what is known as item 47, which is photo id no. 112? Do you see it?

114 DR. COTTON:

Yes.

115 MR. NEUFELD:

Okay. Do you see any leaves on that bloodstain?

116 DR. COTTON:

No, not that I can see.

117 MR. NEUFELD:

Do you see any deposits of soil on that bloodstain?

118 DR. COTTON:

I don't see any big pieces of anything on the bloodstain.

119 MR. NEUFELD:

Okay. Do you see with your naked eye any small pieces of anything on the bloodstain?

120 DR. COTTON:

Not that I can see in the picture, no.

121 MR. NEUFELD:

Okay. And actually as to--all right. You can have your seat again. Thank you, Dr. Cotton.

122 (The witness complies.)
123 THE COURT:

Mr. Neufeld, I would suggest that you and Mr. Scheck show the graphic to all the jurors so they can see the close-up of that item.

124 MR. NEUFELD:

Thank you, your Honor.

125 (The exhibit is displayed to the jury.)
126 THE COURT:

All right. Thank you, counsel.

127 MR. NEUFELD:

And, Dr. Cotton, you mentioned on direct examination that one way to assess if there's going to be an interference with the DNA typing is to do what's called a substrate control; is that correct?

128 MR. CLARKE:

Objection. Vague.

129 THE COURT:

Overruled.

130 DR. COTTON:

I don't--I wouldn't use the term "Interference." Umm, it just--it only tells you whether or not there was any DNA close to where the stain was taken from.

131 MR. NEUFELD:

Well, doesn't the substrate control also tell you something about the nature of the substrate?

132 MR. CLARKE:

Same objection.

133 THE COURT:

It's vague. Why don't you rephrase it.

134 MR. NEUFELD:

Do you know--what is meant by the term "Substrate," Dr. Cotton?

135 DR. COTTON:

Whatever the stain is deposited on.

136 MR. NEUFELD:

And so the term "Substrate control" refers to taking a control swatch, wet swatch of the actual material that the stain is on; isn't that right?

137 DR. COTTON:

Yes.

138 MR. NEUFELD:

And one piece of information that that substrate control can give you as an examiner is to tell you something about the condition of the substrate, whether or not there are other chemicals present for instance?

139 DR. COTTON:

It doesn't--you're not testing for any other chemicals. The only thing you're testing for is the presence of human DNA, and the only way you detect that is if you have a type. So the only thing in--for purposes of DNA, the only thing that substrate control is telling you is whether you had any other human DNA in a position where the substrate control was taken adjacent to the stain.

140 MR. NEUFELD:

Dr. Cotton, through Mr. Clarke's hypothetical, asking whether or not certain samples could be degraded as a result of their contact with soil and leaf stains or leaf material, what I'm asking you is, if the substrate control is taken right next to the bloodstain, could that be a useful indication or provider of information to see whether or not the swatch right next to the stain has soil on it or leaf stains? Would that be something that you could look at?

141 MR. CLARKE:

Objection. Vague.

142 THE COURT:

Overruled.

143 DR. COTTON:

You could look at it with your eyes and you could say, well, it's green or it's brown or whatever, but that's not any kind of scientific procedure to tell you what was on that substrate and then been transferred to the substrate control. You'd have to do some other kind of test.

144 MR. NEUFELD:

So there is testing that could be done to determine whether or not there is soil present on that control?

145 DR. COTTON:

I have no idea. That's outside my area of knowledge.

146 MR. NEUFELD:

Now, I think you also said that soil itself can cause degradation, correct?

147 DR. COTTON:

Well, the presumption is, it's the bacteria in the soil that's causing the degradation.

148 MR. NEUFELD:

So if the stains were brought into contact not only with the sealed plastic bag and heat and moisture over a period of time, but also soil, the combined effect of all those different factors can further enhance degradation than if there was no soil present?

149 DR. COTTON:

Yes.

150 MR. NEUFELD:

And, Dr. Cotton, has there been any research done as to whether or not soil can inhibit the analyst's ability to detect DNA in a specimen, in a biological specimen?

151 DR. COTTON:

As far as I know, it's not going to inhibit your ability to detect it in terms of--for example, like a slot blot, you could say it's here. It might inhibit your ability to type it if there's a lot of degradation.

152 MR. NEUFELD:

So you're saying that soil only will degrade DNA, but it doesn't have this independent effect, namely of simply inhibiting the ability to--to type it?

153 DR. COTTON:

No. I said it might inhibit your ability to type it, but it wouldn't necessarily inhibit your ability to detect it.

154 MR. NEUFELD:

Now, there's already been testimony in this case, Dr. Cotton, about the amount of blood in the blood vial containing Mr. Simpson's reference sample. I wish to ask you a hypothetical question. If 1.5 milliliters of Mr. Simpson's reference sample was unaccounted for in that vial, approximately how many microliters of blood would that be able to produce?

155 MR. CLARKE:

Objection. Assumes facts not in evidence.

156 THE COURT:

Overruled.

157 MR. CLARKE:

Also beyond the scope.

158 THE COURT:

Sustained.

159 MR. NEUFELD:

You talked on direct examination, Dr. Cotton, about the special sensitivity of DNA typing. Do you recall that?

160 DR. COTTON:

I recall talking about issues of what tests were more sensitive than what other tests.

161 MR. NEUFELD:

And you also talked about some of the safeguards that are necessary because of the particular sensitivity of PCR amplification. Do you recall that?

162 DR. COTTON:

Yes, I do.

163 MR. NEUFELD:

And would you agree that given the exquisite sensitivity of PCR amplification, it is essential that even greater safeguards be taken to avoid contaminating evidence collected than would ordinarily be used?

164 THE COURT:

Why don't you rephrase that question? The concern is the term "Exquisite" is without definition at this point.

165 MR. NEUFELD:

All right.

166 MR. NEUFELD:

Have you ever heard the term "Exquisite sensitivity" applied to PCR amplification?

167 DR. COTTON:

I don't know that I've heard that particular term.

"Exquisite" isn't something you would normally see in the scientific nomenclature.

168 MR. NEUFELD:

Well, how about extraordinary sensitivity? Would that be more appropriate to describe what happens to PCR amplification?

169 DR. COTTON:

It's very sensitive. To me, it doesn't seem extraordinary giving--given what we know about how well the reaction works. But if you compare it to other tests, then it is much more sensitive than other types of tests.

170 MR. NEUFELD:

And as a result of that much, much greater sensitivity, would you agree that it's essential to have even greater safeguards to prevent any kind of cross-contamination of the evidence collected?

171 MR. CLARKE:

Objection. Vague.

172 THE COURT:

Sustained. Rephrase the question.

173 MR. NEUFELD:

Would you agree that special safeguards have to be taken in collecting biological specimens to avoid cross-contamination given the heightened and extreme sensitivity of the PCR amplification test?

174 MR. CLARKE:

Objection. Beyond the scope.

175 THE COURT:

Overruled. Doctor, do you understand the question?

176 DR. COTTON:

Is he asking me whether or not--

177 THE COURT:

Well, let me ask you this. Well, let me ask you this.

178 DR. COTTON:

I don't know about how evidence is collected at a scene. So I'm having trouble with the question.

179 THE COURT:

All right.

180 MR. NEUFELD:

Even without knowing how it's collected at a scene, but knowing how sensitive PCR typing is and based on your expertise as a molecular biologist and as a forensic scientist, would you agree that special safeguards have to be taken in the collection and preservation of biological specimens that are intended to be subjected to PCR amplification?

181 MR. CLARKE:

Objection. Beyond the scope.

182 THE COURT:

Overruled.

183 DR. COTTON:

When you use the term "Special"--when the evidence is collected and--it should be handled in a way to minimize contamination. When you saw should you take special safeguards, I would expect that the same safeguards would be applied whether you were doing serology or RFLP or PCR. You don't want contamination between samples regardless of what kind of testing that you're using.

184 MR. NEUFELD:

In your laboratory, Dr. Cotton, isn't it true that over and above the safeguards and controls that you use for RFLP testing, you have additional safeguards for PCR testing?

185 MR. CLARKE:

Objection. Asked and answered.

186 THE COURT:

Overruled.

187 DR. COTTON:

Yes, that's true. But the--many of those safeguards are now because in the laboratory, there is the existence of amplified product. And, therefore--which isn't going to be out where evidence is collected. So many of those extra safeguards are designed so that you can not get amplified product back to your original sample. Now, that's not a hundred percent of them, but that's a good part of them.

188 MR. NEUFELD:

And by the way, in your laboratory, to avoid the possibility of getting that amplified product back to the original location, I believe you said that you have a series of different rooms that the item of evidence moves through and it's a one-way street; is that correct?

189 DR. COTTON:

Yes.

190 MR. NEUFELD:

Do you have any knowledge, Dr. Cotton, as to whether or not the Los Angeles Police Department laboratory--

191 THE COURT:

Sustained.

192 MR. NEUFELD:

The PCR amplification test that you utilize doesn't have the capacity to discriminate whether it's amplifying the original target DNA or a subsequent cross contaminant; isn't that correct?

193 DR. COTTON:

That's correct.

194 MR. NEUFELD:

And since it doesn't have that capacity, Dr. Cotton, would you agree that even a minute contaminant could be amplified perhaps a million times or more during the amplification process?

195 MR. CLARKE:

Objection. Asked and answered.

196 THE COURT:

Sustained.

197 MR. NEUFELD:

Well, as a scientist, Dr. Cotton, have you ever heard the expression, "Garbage in, garbage out"?

198 MR. CLARKE:

Objection. Argumentative.

199 THE COURT:

Sustained. Sustained.

200 MR. NEUFELD:

All right.

201 THE COURT:

And I think as lay people, we've all heard the expression too.

202 MR. NEUFELD:

Hope so.

203 THE COURT:

All right.

204 MR. NEUFELD:

Well, in your laboratory, have you been taught and have you taught others that while working with a bloodstain, one shouldn't do anything which could leave even a minute portion of the stain on your clothing so as to risk cross-contamination?

205 DR. COTTON:

Yes. We generally try not to get the bloodstains on our clothing.

206 MR. NEUFELD:

And does your laboratory in fact have a written manual to spell out the safeguards that must be followed to reduce the chances of cross-contamination in your laboratory?

207 DR. COTTON:

Yes. Those procedures that are designed to reduce cross-contamination are laid out in the standard operating procedure.

208 MR. NEUFELD:

And is everyone in the laboratory who handles biological material required to be familiar with those written safeguards?

209 DR. COTTON:

Everyone in the laboratory who handles evidence is required to be aware and follow those safeguards.

210 MR. NEUFELD:

Thank you. And these safeguards are mandatory; are they not?

211 DR. COTTON:

In terms of our laboratory--

212 MR. NEUFELD:

They're not simply suggestions?

213 MR. CLARKE:

Objection. Asked and answered.

214 THE COURT:

Overruled. But you need to allow her to finish answering the question.

215 DR. COTTON:

In terms of our laboratory, they are mandatory. We're not just saying we hope you'll do a particular thing. We're saying we will all do this particular thing.

216 MR. NEUFELD:

Now, in this case, there's been testimony by Gregory Matheson that the criminalists at the Los Angeles Police Department are not required to change their gloves in between the handling of each piece of evidence.

217 THE COURT:

Sustained.

218 MR. CLARKE:

Objection.

219 THE COURT:

Sustained.

220 MR. NEUFELD:

Can we have a sidebar, please?

221 THE COURT:

Nope. She's testifying about the testing that was done at Cellmark.

222 MR. NEUFELD:

As in--

223 THE COURT:

And you've already--she has no idea about the handling, packaging, collection of the evidence. We've established that. Let's move on.

224 MR. NEUFELD:

May I ask questions that occurred at the laboratory as opposed to at the crime scene and ask her opinion as an expert?

225 THE COURT:

It's irrelevant.

226 MR. NEUFELD:

All right.

227 MR. NEUFELD:

At Cellmark diagnostics laboratory, Dr. Cotton, is glove changing between each item required to avoid any kind of cross-contamination?

228 DR. COTTON:

Can you be--what do you mean, between each item?

229 MR. NEUFELD:

Well, if a molecular biologist at Cellmark handles one item of evidence, let's say 47, for instance, in our case and does some manipulation with the item using different pieces of equipment and then packs up that item and now takes out a second item of evidence, is the molecular biologist at Cellmark required to change his or her gloves before moving on to the next item?

230 DR. COTTON:

They're not required to and they normally--if they haven't touched the item with their gloves, that is, if they've handled it with forceps or a scalpel or something and they haven't touched it, then they may not change their gloves in between handling the first item and the second item.

231 MR. NEUFELD:

Referring you--you have a protocol you said that has been prepared by Cellmark for the use of all personnel that handles biological items of evidence in the laboratory; is that correct?

232 DR. COTTON:

Yes.

233 MR. NEUFELD:

Dr. Cotton, and there's a section in your written protocol dealing with the handling of evidence during preparation for analysis; isn't that correct?

234 DR. COTTON:

Yes, there is.

235 MR. NEUFELD:

Isn't it a fact, Dr. Cotton, that in that protocol, it states, quote, "Clean disposable gloves must be worn when handling evidence samples. To avoid cross-contamination of evidence, gloves are changed between samples," closed quotes?

KEY QUOTE
236 DR. COTTON:

May I see it, please?

237 MR. NEUFELD:

Certainly.

238 (Brief pause.)
239 DR. COTTON:

Yes.

240 MR. NEUFELD:

Did I accurately read from your protocol?

241 DR. COTTON:

Yes you did.

242 MR. NEUFELD:

Now--

243 MR. NEUFELD:

One moment.

244 (Discussion held off the record between Defense counsel.)
245 MR. NEUFELD:

At Cellmark, are the scientists instructed in writing to change the bench paper that is used in manipulating samples in between the handling of each sample?

246 DR. COTTON:

Yes. Excuse me. My voice is getting a little rough. Go ahead.

247 MR. NEUFELD:

And at Cellmark, Dr. Cotton, when your technicians and electrobiologists--your scientists--excuse me--when your scientists manipulate the items with pieces of equipment, isn't it required that they either dispose of the equipment between items or put it into a beaker of bleach?

248 DR. COTTON:

They will either dispose of it if it's a disposable piece of equipment or they will clean it with bleach or alcohol.

249 MR. NEUFELD:

And would you agree, Dr. Cotton, that bleach is a very effect--is very effective at instantly degrading DNA, that is, in breaking it down?

250 DR. COTTON:

Yes.

251 MR. NEUFELD:

And that's the reason why your laboratory uses bleach; is it not?

252 DR. COTTON:

Yes.

253 MR. NEUFELD:

And would you agree, Dr. Cotton, that simply wiping a piece of equipment with a chem-wipe or distilled water will not be as effective as either disposing of the equipment or dropping it into a beaker of bleach?

254 MR. CLARKE:

Objection. Vague. Also beyond the scope.

255 THE COURT:

Overruled.

256 DR. COTTON:

I would prefer wiping it down with bleach or alcohol as opposed to wiping it down with water. Wiping it down with water is better than not wiping it down at all.

257 MR. NEUFELD:

Well, granted. But you would agree, Dr. Cotton, that if you're really concerned with getting rid of any lingering DNA or biological material that may be invisible to the naked eye on a piece of equipment, bleach is a far better tool for doing that than simple distilled water?

258 DR. COTTON:

Well, remember, at that point, you don't have naked DNA. I mean, you still got cells there, and the bleach has to get to the DNA in order to destroy it. So it may be just as effective or may not. I don't really know.

259 MR. NEUFELD:

Do you know anything at all, Dr. Cotton, about whether or not water alone will kill and degrade DNA?

260 DR. COTTON:

No, it won't.

261 MR. NEUFELD:

Okay. Another point that you made, Dr. Cotton, I believe on direct examination is that it is important not to rush these tests; is that correct?

262 MR. CLARKE:

Objection. Vague.

263 THE COURT:

Overruled.

264 DR. COTTON:

I don't think I said a thing about rushing the tests.

265 MR. NEUFELD:

Well, I think you said to Mr. Clarke that if you had no other cases going on in the laboratory and you were conducting a PCR test from beginning to end, in other words, from the moment you received the samples from an outside law enforcement agency until you get the dots on the strips, that you could get results in as little as a few days I believe you said. And if it's not a few days, please correct me.

266 DR. COTTON:

No. You could get resu--well, if you worked a really long day, you could start one sample at the beginning and get results by the end.

267 MR. NEUFELD:

What's a really long day? What time would you have to start to do that?

268 DR. COTTON:

Well, it's--you know, depends on what kind of DNA extraction you do. Some of them are shorter than others. So if you do a short one and then you set up your amplification--so say your short one took an hour, your amplification set-up takes a half hour, your amplification takes about two and a half hours, what is that? Up to four or so. And then the typing itself takes about two more hours. So--and given that you're taking some pauses in between, if you worked all day, you could get--and you didn't have anything else to do, you could get a type--if you started in the morning, you could get a type by the end of the day.

269 MR. NEUFELD:

How about if you were working with a dozen different items?

270 DR. COTTON:

Uh, well, then it would make your day longer.

271 MR. NEUFELD:

But you could still do it in one day?

272 DR. COTTON:

Yes.

273 MR. NEUFELD:

Have you ever done PCR typing on evidence specimens in groups of a dozen that quickly in your laboratory in actual casework?

274 DR. COTTON:

I don't really know.

275 MR. NEUFELD:

Now, you said that at Cellmark I believe, the room where the evidence is handled, I think you referred to it as, quote, a biological safety cabinet, unquote. Was that the term you used?

276 DR. COTTON:

No. What--what I said was that the DNA extraction was done in a biological safety cabinet. And it's not a room. It's a--it's a thing. It's a piece of equipment.

277 MR. NEUFELD:

And it's called a biological safety cabinet?

278 DR. COTTON:

Yeah, or a hood. Call it a hood.

279 MR. NEUFELD:

And does that hood prevent air flow from outside the cabinet area from coming inside the cabinet area?

280 DR. COTTON:

Yes, it does.

281 MR. NEUFELD:

And what is the reason that you want to prevent air from outside the cabinet area coming inside the cabinet area where you're doing the extractions?

282 DR. COTTON:

Well, in reality--it also prevents what's inside the cabinet from coming outside. And the first reason to use the cabinet is the protection of the analyst because, as most of you probably know, blood samples can contain viruses that can be very harmful. So first reason is to protect the analyst. Second reason is to protect the evidence.

283 MR. NEUFELD:

And when you say, "Protect the evidence," you want to avoid again cross-contamination with this--this biological cabinet; isn't that correct?

284 DR. COTTON:

Yes. It's the area in which the DNA extraction is done. It's not the area--for example, if they--uh, they may handle evidence outside on the bench. For example, they wouldn't handle a hair in the biological safety cabinet because the air flow is sufficient that you might blow it away. So you wouldn't want to do that.

285 MR. NEUFELD:

Is what you're talking about is a laminal flow hood?

286 DR. COTTON:

Yes. A laminal flow hood.

287 MR. NEUFELD:

Thank you. Have you ever inspected the Los Angeles Police Department SID laboratory?

288 THE COURT:

Counsel, sustained.

289 MR. NEUFELD:

And in your laboratory, to avoid cross-contamination, do you do your extractions on evidence at a separate time and place than when you do your DNA extractions on a reference sample?

290 DR. COTTON:

At a separate time, not a separate place.

291 MR. NEUFELD:

And when you say a separate time, how much time is there separated between the extractions?

292 DR. COTTON:

Well, it could be just a matter of minutes if you did one, put it away and then got the other one out, or it could be a matter of days or months, depending on when the various items were actually received.

293 MR. NEUFELD:

And do you keep the extraction of the reference sample separate from the other extractions until you get to the amplification stage?

294 DR. COTTON:

That's right.

295 MR. NEUFELD:

And why do you do that?

296 DR. COTTON:

We did that--we set that up in response to the results that we got on the second group of CACLD proficiency tests where we clearly had some contamination that we couldn't determine precisely where it came from.

KEY QUOTE
297 MR. NEUFELD:

Would it be fair to say that one danger of doing the extraction on the reference sample at the same time that you do the extraction on the various items of evidence is that you could get cross-contamination from the much more enriched DNA in the reference sample?

298 DR. COTTON:

Yes. I think that's what I just said.

299 MR. NEUFELD:

And as a result of that kind of cross-contamination from the more enriched reference sample, couldn't that lead to a false positive in the evidentiary specimens?

300 MR. CLARKE:

Objection. I think this is asked and answered.

301 THE COURT:

Overruled.

302 DR. COTTON:

Yes, it could.

303 MR. NEUFELD:

Okay. Now--by the way, Dr. Cotton, under your own laboratory's procedures, would you extract two different--would you extract samples from two different crime scenes at the same time as one another?

304 MR. CLARKE:

Objection. Beyond the scope.

305 THE COURT:

Overruled.

306 DR. COTTON:

Yes, we might.

307 MR. NEUFELD:

If you were told by the submitting agency, Dr. Cotton, that samples from one location--that samples from one location had much more DNA than samples from the other location, would that influence your decision to extract those samples separately?

308 DR. COTTON:

Well, in general--the answer is no because--but it's because people are asking us to do the DNA test. They're not ever telling us, "You have this much DNA. So now go do your DNA test." Usually we are getting samples because the submitting agency doesn't have the same capabilities as we do.

309 MR. NEUFELD:

Well, would you like to know before you decide whether these samples should be extracted together or separately whether some of the samples have much more blood on them than other samples?

310 DR. COTTON:

Well, you might like to know that, but that's almost all the time not possible to know unless you're looking at the physical size. You have a stain that's a foot versus a stain that's an inch, obviously it's likely that the big one will have more than the little one. But apart--and then you wouldn't use the whole big one anyway. You would cut out a small piece. So--

311 MR. NEUFELD:

So, for instance--

312 MR. CLARKE:

I'm sorry. Could the witness finish her answer?

313 THE COURT:

Yes.

314 DR. COTTON:

So most of the time, you simply can't know that because you don't know how much DNA there is on the stain just by looking at it.

315 MR. NEUFELD:

For instance, in this case, Dr. Cotton, there's been testimony that when item 12 was collected from inside the foyer of Mr. Simpson's home, there was a collection of three drops of blood as opposed to the stains at Bundy, which were taken from a single drop of blood. Is that a factor that you might wish to know or might consider in determining whether or not the extraction should be done at the same time or done separately?

316 DR. COTTON:

No.

317 MR. NEUFELD:

One moment, please.

318 (Discussion held off the record between Defense counsel.)
319 MR. NEUFELD:

Just to go back one step for a moment, Dr. Cotton, you were mentioning the laminal flow hood that you have in the room where you do the extraction for DNA?

320 DR. COTTON:

Yes.

321 MR. NEUFELD:

Is the purpose of that laminal flow hood to create literally a wall of air which separates the rest of the room from that work area?

322 DR. COTTON:

Yes.

323 MR. NEUFELD:

It's not the purpose of a laminal flow hood to simply pull air from the lab into the work area and then outside, is it?

324 DR. COTTON:

No.

325 MR. NEUFELD:

Dr. Cotton, you said sometimes the submitting agency can't give you information about relative quantities of DNA because that's why they're submitting it to you for testing; is that correct?

326 DR. COTTON:

That's right.

327 MR. NEUFELD:

But there have also been instances, have there not, Dr. Cotton, where the submitting agency itself has conducted DNA testing on the same items or some of the same items even before it is given to you? Isn't that correct?

328 DR. COTTON:

That's right.

329 MR. NEUFELD:

And do you know whether in this case, LAPD had in fact conducted DNA testing on some of the same items that they gave to you before they sent them to you?

330 MR. CLARKE:

Objection. Vague. Vague as to "Items."

331 THE COURT:

Overruled. Are you aware of that?

332 DR. COTTON:

I'm vaguely aware that they may have done some testing. I don't have any information on what items--that I recall having anyway, on what items had been or had not been tested. We did not--

333 MR. NEUFELD:

I'm sorry.

334 DR. COTTON:

We did not receive any DNA, extracted DNA from LAPD.

335 MR. NEUFELD:

Well, assume for purpose of this hypothetical that the Los Angeles Police Department had in fact the--as of June 14th, run PCR tests on every single one of the Bundy drops.

336 DR. COTTON:

Okay.

337 MR. NEUFELD:

As a result of that--

338 MR. CLARKE:

Excuse me. Objection. Improper hypothetical.

339 THE COURT:

Sustained.

340 MR. NEUFELD:

All right. Assume hypothetically, for purpose of this hypothetical, that the Los Angeles Police Department had run PCR testing on items 47, 48, 49, 50 and 52. Okay?

341 DR. COTTON:

Okay.

342 MR. CLARKE:

Again, objection. Improper hypothetical.

343 THE COURT:

Sustained.

344 (Discussion held off the record between Defense counsel.)
345 MR. NEUFELD:

Assume for the purpose of this hypothetical that the Los Angeles Police Department had run PCR testing from beginning to end on items 47, 48, 49, 50 and 52 before--

346 MR. CLARKE:

Same objection.

347 THE COURT:

Sustained.

348 MR. NEUFELD:

--before they were ever sent to you?

349 MR. CLARKE:

Objection. I'm sorry, your Honor.

350 THE COURT:

Sustained.

351 MR. NEUFELD:

May I have a sidebar, your Honor?

352 THE COURT:

Proceed.

353 MR. NEUFELD:

Dr. Cotton, if a laboratory had done PCR typing on the samples that they were submitting to you, wouldn't you want that laboratory to provide you with as much information as possible about the quality and quantity of those samples?

354 MR. CLARKE:

Same objection, your Honor.

355 THE COURT:

Overruled.

356 DR. COTTON:

It really probably wouldn't make any difference because we would be doing that assessment as we went along.

357 MR. NEUFELD:

Well, would you agree that you do not want to process or do extractions at the same time of samples that have very, very little DNA with samples that may have relatively large amounts of DNA? Would you agree with that?

358 MR. CLARKE:

I'm sorry. Objection. Vague.

359 THE COURT:

Overruled.

360 DR. COTTON:

If there was a way to know that, then--and depending on the differences in amounts--

361 MR. NEUFELD:

Right.

362 DR. COTTON:

--you might try to not do the extractions at the same time. But for the most part, there isn't a way to know that and--never--I'll stop there.

363 MR. NEUFELD:

Well, one of the ways that you knew it is, you can do a yield gel, correct?

364 DR. COTTON:

Yes.

365 MR. NEUFELD:

Another way you can do it is, you can do a slot blot, correct?

366 DR. COTTON:

Yes.

367 MR. NEUFELD:

So if the submitting agency had done some of those tests to quantify and to give a qualitative assessment of the DNA, wouldn't that be useful information for you to have in advance if in fact some of the samples had much more DNA than other samples?

368 MR. CLARKE:

Objection. Irrelevant. I think asked and answered.

369 THE COURT:

Sustained. Did you have any information about any prior testing in this case prior to Cellmark doing its testing.

370 DR. COTTON:

Not that I remember.

371 THE COURT:

Thank you. Proceed.

372 DR. COTTON:

With the exception of the DOJ samples that we got as extracted DNA. We did receive information on quantitations on those samples.

373 THE COURT:

Proceed.

374 MR. NEUFELD:

When you say you didn't receive any information, Dr. Cotton, you're not saying there wasn't any information. You're just saying that nothing was communicated to you; is that correct?

375 DR. COTTON:

That's right. I have no idea whether there was or was not any information.

376 (Discussion held off the record between Defense counsel.)
377 MR. NEUFELD:

In fact, Dr. Cotton, doesn't the user's guide, the manufacturer's user's guide for the kits that you use for PCR typing explicitly state that to perform DNA extractions from samples containing high levels of DNA separately from those samples containing low levels of DNA?

378 DR. COTTON:

Are you talking about the ampli-type guide?

379 MR. NEUFELD:

Yes.

380 DR. COTTON:

It may say that in there. I don't remember exactly, but--you know, it's a pretty big book. But I wouldn't be surprised.

381 MR. NEUFELD:

And if it said that in bold type in the book, would you take that to mean that that was the strong recommendation of the manufacturer of the kit that you're relying on?

382 MR. CLARKE:

Objection. Assumes facts not in evidence.

383 MR. NEUFELD:

Well--

384 THE COURT:

Overruled. Overruled.

385 DR. COTTON:

It might be the strong man recommendation of the manufacturer of the kit. However, the manufacturer of the kit is not a group that's engaged in routine forensic DNA typing. So --

386 MR. NEUFELD:

Was this kit--

387 MR. CLARKE:

I'm sorry. Could the witness finish her answer?

388 MR. NEUFELD:

I thought she had. I apologize.

389 DR. COTTON:

So a laboratory with some experience might--like any recommendation, might decide to accept that recommendation or not accept it.

390 MR. NEUFELD:

Isn't there a statement actually on the kit by the manufacturer that this kit is designed for forensic application?

391 DR. COTTON:

That's right. But the manufacturer of the kit is not a forensic DNA lab.

392 MR. NEUFELD:

To your knowledge--

393 MR. CLARKE:

I'm sorry. Could the witness finish her answer, please?

394 DR. COTTON:

I'm done.

395 THE COURT:

All right. Proceed.

396 MR. NEUFELD:

Isn't the kit explicitly and expressly warranted to work only if you follow the directions on the kit? Isn't that a warranty given by the manufacturer?

397 DR. COTTON:

Yes. But that's in terms of the salt solution concentrations and the temperature and the quantitation, that is the amount of DNA you add. There's no specific directions they can give you to ensure that the rest of your handling is good or bad. They can only tell you if you have the thing at 60 degrees, it will work, and if you don't, it won't.

398 MR. NEUFELD:

So is it just--so I'm clear on this, is it your position that the expressed instruction from the manufacturer that you are, quote, "To perform DNA extractions from samples containing high levels of DNA separately from samples containing a low level of DNA" is something that the people who utilize this kit are free to ignore?

399 DR. COTTON:

Yes.

400 MR. CLARKE:

Excuse me. Objection. I'll withdraw the objection.

401 DR. COTTON:

Yes. And I mean there--what's high and what's low? I mean, this is going to be the judgment of the people in the laboratory. That's not a specific instruction. It's a vague instruction.

KEY QUOTE
402 MR. NEUFELD:

Granted, Dr. Cotton, what's high and what's low is something that has to be determined by the particular laboratory. But once that assessment is made as to what is high and what is low, wouldn't you agree that it's critically important to follow the instruction that once--that that what you consider a high level of DNA should not be extracted at the same time with that what you consider a low level of DNA?

403 MR. CLARKE:

Objection. Asked and answered and I think counsel is arguing with the witness.

404 THE COURT:

Overruled. We have asked this question. Again, I'll allow the question and answer one last time.

405 DR. COTTON:

I have stated I think earlier that when--depending on how great a difference in amount of DNA you have, if it's a very great difference, then one would prefer if you were able to know ahead of time to deal with the large amounts of DNA or evidence that had a large amount of material on it separately from the smaller amount, and that's a relative decision for any specific laboratory.

406 MR. NEUFELD:

Is the manufacturer of the kit the same entity that designed the validation studies for that kit?

407 DR. COTTON:

Well, they certainly did a lot of validation studies, but they are not the only group that did validation studies using that kit.

408 MR. NEUFELD:

Now, you mentioned in terms of your testing of items in this case that one of the items you were asked to do DNA profiling was the steering wheel inside the Bronco; is that right?

409 DR. COTTON:

Uh, from one item of evidence, from the--I don't know if there's more than one item of evidence from the steering wheel. So--we had an item of evidence from the steering wheel.

410 MR. NEUFELD:

And that one item of evidence was a blood swatch taken from a smear on the steering wheel; is that correct?

411 DR. COTTON:

That's right.

412 MR. NEUFELD:

Help me get the board.

413 (Discussion held off the record between Defense counsel.)
414 MR. NEUFELD:

Now, would you agree, Dr. Cotton, that interpreting mixed stains is a more demanding challenge to the forensic laboratory than interpreting a stain that only has a single source?

415 DR. COTTON:

Sure.

416 MR. NEUFELD:

And when you see more than two versions of a particular gene, that enables you to determine that there's more than one contributor to that stain, correct?

417 DR. COTTON:

Yes.

418 MR. NEUFELD:

However, if you see three or four versions of the gene, you can't necessarily tell whether there's been two contributors or three contributors or more contributors; isn't that correct?

419 DR. COTTON:

That's exactly right.

420 MR. NEUFELD:

And that's one of the difficulties in interpreting mixed stains?

421 DR. COTTON:

Yes.

422 MR. NEUFELD:

And with respect to the stain removed from the steering wheel of Mr. Simpson's Bronco, your DQ-Alpha typing method showed the presence of three different alleles; is that correct?

423 DR. COTTON:

That's right.

424 MR. NEUFELD:

And I think you said yesterday, the day before that and the day before that one should only inherit two versions of a gene; isn't that correct?

425 DR. COTTON:

Yes, except under very rare circumstances. So we'll just assume two.

426 MR. NEUFELD:

All right. So certainly, Dr. Cotton, each of the individuals who you typed in this case as reference samples, namely, Mr. Simpson, Nicole Brown Simpson and Ronald Goldman, each had only two alleles for the DQ-Alpha marker?

427 DR. COTTON:

Yes.

428 MR. NEUFELD:

And when you typed the DQ-Alpha markers--I'm sorry. When you typed that stain on the steering wheel, you found that there were three separate DNA types, correct?

429 DR. COTTON:

Yes, we did.

430 MR. NEUFELD:

You found the 1.1 version of the gene present, right?

431 DR. COTTON:

Yes.

432 MR. NEUFELD:

You found the 1.2 version of the gene present, correct?

433 DR. COTTON:

Yes.

434 MR. NEUFELD:

And you found the number 4 version of that same gene present?

435 DR. COTTON:

Yes.

436 MR. NEUFELD:

And initially on this board that you saw, the Prosecution had written that the only one of the three people not excluded was Mr. Simpson, correct?

437 DR. COTTON:

Yes.

438 MR. NEUFELD:

But I take it you did not help the Prosecution prepare this exhibit board, did you?

439 DR. COTTON:

I saw some of the boards to make sure that they were right and I don't know if I--I--I don't remember if I saw this one. I may have. I might have.

440 MR. NEUFELD:

But the reason--

441 DR. COTTON:

But there was a mistake on it.

442 MR. NEUFELD:

Okay. And the reason--looking up at the top, you said that Mr. Simpson is of a--

443 MR. NEUFELD:

Can everyone see the top?

444 MR. NEUFELD:

Okay. Looking up at the top, that Mr. Simpson is a type 1.1, 1.2?

445 DR. COTTON:

Yes, he is.

446 MR. NEUFELD:

And you can see a 1.1, 1.2 in this mixture?

447 DR. COTTON:

Yes.

448 MR. NEUFELD:

And that's why he's included?

449 DR. COTTON:

Well, and the poly-marker data as well.

450 MR. NEUFELD:

Fine. Well, actually on the poly-marker data if you look at it, isn't every different version of every poly-marker included in this mixture?

451 DR. COTTON:

Uh, I don't remember without going back and looking.

452 MR. NEUFELD:

Please take a look.

453 DR. COTTON:

What's the--we're at 29.

454 MR. NEUFELD:

29.

455 DR. COTTON:

Okay.

456 (The witness complies.)
457 DR. COTTON:

Yes. You're correct. There are--all the possible alleles for the poly-marker are present in that sample.

458 MR. NEUFELD:

So in fact, if you just looked at the poly-markers and nothing else in this case, you would have to say that there would be almost no useful information in the poly-marker results because the entire human population could have contributed to that mixture?

459 DR. COTTON:

Assum--yeah, assuming all the intensities were--of the dots were--assuming the dot intensities weren't informative, and I don't recall that they are.

460 MR. NEUFELD:

Okay. So the key information here in this particular case for you was not the poly-marker results, but rather DQ-Alpha results?

461 DR. COTTON:

For this sample.

462 MR. NEUFELD:

Yes. And not only were you able to not exclude Mr. Simpson, but you were not able to exclude Nicole Brown Simpson; isn't that right?

463 DR. COTTON:

That's right.

464 MR. NEUFELD:

And that's because Nicole Brown Simpson is a DQ-Alpha type 1.1, 1.1, right?

465 DR. COTTON:

That's right.

466 MR. NEUFELD:

Meaning that she inherited the same version of the gene from her mother and her father?

467 DR. COTTON:

Exactly.

468 MR. NEUFELD:

And so because you see the 1.1 allele present in this mixture, that 1.1 allele could simply be two copies of--of the DQ-Alpha typing from Nicole Brown Simpson?

469 DR. COTTON:

Yes.

470 MR. NEUFELD:

However, you in fact excluded Ronald Goldman as a contributor to this mixture; isn't that correct?

471 DR. COTTON:

Yes, we did.

472 MR. NEUFELD:

And the reason you excluded Mr. Goldberg as a contributor to this mixture is that Ronald Goldman is of a type 1.3, 4, correct?

473 DR. COTTON:

That's right.

474 MR. NEUFELD:

And what that means is is that Ronald Goldman, his DQ-Alpha type has two alleles in it which are different from one another, correct?

475 DR. COTTON:

That's right.

476 MR. NEUFELD:

One of his alleles is a 4 allele, right?

477 DR. COTTON:

Yes.

478 MR. NEUFELD:

One of his alleles is the 1.3 allele, correct?

479 DR. COTTON:

Yes.

480 MR. NEUFELD:

And so if this sample contained a portion of Ronald Goldman's blood or biological material, you would also expect to see the 1.3 allele and not just the 4 allele?

481 DR. COTTON:

Yes.

482 MR. NEUFELD:

And it was on the basis of that that you excluded Ronald Goldman as being one of the contributors to this mixture?

483 DR. COTTON:

That's exactly right.

484 MR. NEUFELD:

So would you agree, Dr. Cotton, that based on your analysis, that the number 4 allele that you see present in this mixture from the steering wheel must come from someone other than Mr. O.J. Simpson, Nicole Simpson Brown and Ronald Goldman? Isn't that correct?

485 DR. COTTON:

I would.

486 MR. NEUFELD:

Now, this other person--

487 MR. NEUFELD:

Let me just get out my diagram.

488 (Brief pause.)
489 MR. NEUFELD:

Do we have the other small easel? Barry, help me, please.

490 (Discussion held off the record between Defense counsel.)
491 THE COURT:

Mr. Scheck, perhaps we ought to move that over here because that one height wise is hard to see unless it's in the middle.

492 MR. SCHECK:

This is not my area. I've established that.

493 THE COURT:

So stipulated. All right. Mr. Neufeld, can you work with this?

494 MR. NEUFELD:

Given my art work, I'm sure it will be adequate.

495 THE COURT:

All right. Mr. Scheck, you may need to--Mr. Scheck, don't go away. You may need to steady that.

496 MR. SCHECK:

All right.

497 MR. NEUFELD:

You can do better than that. Can't you make it straight? Only a Californian could teach a New Yorker how to do that.

498 MR. NEUFELD:

All right. Dr. Cotton, now, this third person who cannot be Mr. Goldberg and cannot be Nicole Simpson, Nicole Brown Simpson and could not be Ronald Goldman, who has--we'll call him--all right. We'll call him actually the fourth person because he's none of the three people whose reference samples you tested, all right?

499 MR. CLARKE:

Objection. Vague.

500 THE COURT:

Overruled.

501 MR. NEUFELD:

This fourth person has the 4 allele, correct, has one of his two or one of her two alleles, correct?

502 DR. COTTON:

Well, yes, if we assume a person in there has a 4 allele.

503 MR. NEUFELD:

Okay. Let's start with the most simple assumption first. All right?

504 DR. COTTON:

Okay.

505 MR. NEUFELD:

Now, this person who has the 4 allele also has two alleles, inherited one from his mother and one from his father or one from her mother and one from her father, correct?

506 DR. COTTON:

Yes.

507 MR. NEUFELD:

And so this person could have different possible genotypes as well, correct?

508 DR. COTTON:

Of course.

509 MR. NEUFELD:

This person could be, given the presence of the 1.1 and 1.2, could have as a genotype a 1.1, 4, correct?

510 DR. COTTON:

Yes.

511 MR. NEUFELD:

This person could have as a--I'll move in a second. I'm sorry. This person could have as a genotype a 1.2, 4. Woops. All right. A 1.2, 4, correct?

512 DR. COTTON:

Yes.

513 MR. NEUFELD:

And this person--and this person could also have inherited the same version of the gene from both parents and be a 4,4, correct?

514 DR. COTTON:

Yes.

515 MR. NEUFELD:

Okay. And those are three possible explanations for a genotype for a third--for a fourth person if the fourth person contributed the number 4 allele, correct? Those are the possible--

516 DR. COTTON:

Those are the three possible--those are the three possible genotypes for a person in that mixture if that person's first allele is a 4.

517 MR. NEUFELD:

Okay. Now--

518 MR. NEUFELD:

You can take that down. Oh, what would be next in order, your Honor?

519 THE COURT:

That would be 1150.

520 (Deft's 1150 for id = chart)
521 MR. NEUFELD:

Now, Dr. Cotton, I'm going to ask you a hypothetical, and I'm going to ask you whether or not that hypothetical is consistent or inconsistent with the observed evidence in your laboratory. Assume that Mr. Simpson cut himself in his home and walked out to the Bronco to get something from his car and bled in his own Bronco.

522 MR. CLARKE:

Objection. I'm sorry.

523 THE COURT:

Sustained.

524 MR. NEUFELD:

Assume, Dr. Cotton, that some of Mr. Simpson's blood is in his own car.

525 MR. CLARKE:

Same objection, your Honor.

526 THE COURT:

Overruled.

527 MR. NEUFELD:

And assume, Dr. Cotton, that some other person other than Mr. Goldman, other than Nicole Brown Simpson, other than O.J. Simpson had come into contact with the blood of Nicole Brown Simpson and then entered that Bronco and made a smear on the steering wheel, having touched Mr. Simpson's blood--

528 MR. CLARKE:

Same objection, your Honor.

529 THE COURT:

Sustained.

530 MR. NEUFELD:

Dr. Cotton, if somebody else who is either a type--a DNA type 4, 1.1 or 4, 1.2 or 4, 4 touched Mr. Simpson's blood and touched Nicole Brown Simpson's blood and touched that steering wheel, would that be consistent with the stain you found on the wheel?

531 MR. CLARKE:

Objection. Improper hypothetical.

Temperature

tense

Key Quotes (5)

Dr. Robin Cotton
Yes. And I mean there--what's high and what's low? I mean, this is going to be the judgment of the people in the laboratory. That's not a specific instruction. It's a vague instruction.
Cotton admits labs can use their own judgment to ignore the PCR kit manufacturer's explicit instruction to separate high- and low-DNA samples during extraction — an instruction LAPD allegedly did not follow.
Dr. Robin Cotton
We did that--we set that up in response to the results that we got on the second group of CACLD proficiency tests where we clearly had some contamination that we couldn't determine precisely where it came from.
Cotton voluntarily discloses that Cellmark itself once had a contamination incident it couldn't explain — and changed its protocols in response. Implicitly undercuts the idea that labs are immune to such errors.
Dr. Robin Cotton
Yes. There are--all the possible alleles for the poly-marker are present in that sample.
Cotton confirms that the Bronco steering wheel stain contained every possible poly-marker allele — meaning the poly-marker data was useless for exclusion, and the entire human population could have contributed to that mixture.
Peter Neufeld
Isn't it a fact, Dr. Cotton, that in that protocol, it states, quote, 'Clean disposable gloves must be worn when handling evidence samples. To avoid cross-contamination of evidence, gloves are changed between samples,' closed quotes?
Neufeld catches Cotton with her own lab's written protocol, which he then uses to imply LAPD's practices (where glove-changing was not required between samples) fell below accepted standards.
Dr. Robin Cotton
Yes, it could.
Cotton agrees that cross-contamination from a more DNA-enriched reference sample could lead to a false positive in evidentiary specimens — the core contamination hypothesis the defense is building.

Evidence (8)

Defendant's 1149-a through l
Computer-generated graphic visualization showing stepwise DNA degradation from moisture, heat, plastic bag storage, and time, then cross-contamination from a second source
introduced and used as demonstrative aid during testimony
People's 165
Photo board including close-up photograph of item 47 (Bundy bloodstain swatch)
displayed to jury and used to question whether soil or leaves were visible on the stain
Informal
Item 47 — blood swatch from Bundy crime scene (single drop)
discussed regarding degradation factors and absence of visible soil or leaf contamination
Informal
Item 12 — blood drops from inside Simpson's Rockingham foyer (three drops)
referenced in hypothetical about whether quantity difference between items should affect extraction protocols
Informal
Items 48, 49, 50, 52 — Bundy crime scene blood swatches
referenced in sustained hypotheticals about prior LAPD PCR testing
Informal
Cellmark Diagnostics standard operating procedure / written protocol
read into the record; confirmed requirement to change gloves between samples and use bleach to clean equipment
+ 2 more

Notable Exchanges (5)

Peter NeufeldDr. Robin Cotton
Neufeld walks Cotton through her own lab's written protocol on glove-changing, which she confirms requires changing gloves between samples. He had earlier established that LAPD did not have this requirement — drawing the contrast without being able to state it directly due to sustained objections.
strategic
Peter NeufeldDr. Robin Cotton
Neufeld establishes that the PCR kit manufacturer's user guide explicitly instructs users to separate high- and low-DNA extractions, then gets Cotton to admit that experienced labs feel free to override that recommendation as too 'vague.' Cotton then walks back slightly, acknowledging large differences in quantity would warrant separate extraction.
revealing
Peter NeufeldDr. Robin CottonGeorge Clarke
Neufeld attempts four times to pose a hypothetical that LAPD had already run PCR tests on the Bundy items before sending them to Cellmark. All four attempts are sustained on 'improper hypothetical' grounds, leaving the implication hanging without Cotton being able to address it.
strategic
Peter NeufeldDr. Robin Cotton
Examination of the Bronco steering wheel mixture reveals that all poly-marker alleles for every typed individual were present in the stain, making the poly-marker data statistically useless — Cotton confirms 'the entire human population could have contributed.'
revealing
Peter NeufeldLance A. Ito
Neufeld attempts 'garbage in, garbage out' as a scientific metaphor; Ito sustains the argumentative objection and quips that 'as lay people, we've all heard the expression too,' drawing light laughter.
light

Light Moments (3)

Lance A. Ito
After Neufeld's 'garbage in, garbage out' question is sustained as argumentative, Judge Ito remarks: 'And I think as lay people, we've all heard the expression too.' Neufeld replies: 'Hope so.'
Peter Neufeld
Neufeld uses the phrase 'Okey-doke' mid-examination while walking Cotton through the degradation graphic.
Dr. Robin Cotton
Cotton notes mid-testimony: 'Excuse me. My voice is getting a little rough. Go ahead.' — a small humanizing moment in an otherwise dense technical exchange.

Credibility Attacks (3)

⚔ LAPD crime lab protocols (via Cotton)
comparative impeachment using Cellmark's own written procedures
Neufeld established Cellmark's mandatory glove-changing, bench paper replacement, and bleach protocols, then repeatedly implied LAPD fell below these standards — though Ito blocked direct questions about LAPD's lab practices as beyond Cotton's scope.
⚔ LAPD evidence collection and handling (via Cotton)
expert opinion elicitation on contamination risk
Through Cotton's agreement that moisture, heat, plastic bags, soil, and time degrade DNA, and that cross-contamination from a richer reference sample can produce false positives, Neufeld built a chain of logic that LAPD's handling of evidence could explain Simpson's DNA appearing at Bundy.
⚔ Prosecution's Bronco steering wheel exhibit
expert admission — data renders results inconclusive
Cotton confirmed that the Bronco steering wheel mixture contained all possible poly-marker alleles, meaning the poly-marker data excluded no one. The only meaningful data was DQ-Alpha, and Cotton admitted that under the mixture Nicole Brown Simpson was also not excluded — undercutting the prosecution board that listed only Simpson as included.

Witness Demeanor

(Brief pause.) — multiple instances during graphic demonstrations
(The witness complies.) — Cotton returning to witness stand after examining exhibits
Cotton's voice audibly roughening during extended testimony: 'My voice is getting a little rough'
Cotton volunteers a self-correction unprompted: 'But there was a mistake on it' — referring to a prosecution exhibit board she may have reviewed

Objections

28 objections (11 sustained, 15 overruled)
Proceeding 7907 • 531 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 12, 1995 📄 Cross-examination of Dr. Robin
MAY 12, 1995 KRT DvH TD